Medicus Pharma Ltd. (MDCXW) Earnings History
Net Loss5 years of earnings data (2021–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Medicus Pharma Ltd. (MDCXW) Earnings Overview
As of June 29, 2026, Medicus Pharma Ltd. (MDCXW) reported trailing twelve-month net income of -$37M, reflecting -69.0% year-over-year growth. The company earned $-1.25 per diluted share over the past four quarters.
Looking at the long-term picture, MDCXW's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2022.
Medicus Pharma Ltd. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SNDX (-$243M net income, -165.6% margin), TGTX ($462M net income, 72.6% margin), CRVS (-$44M net income), MDCXW has comparable earnings metrics. Compare MDCXW vs SNDX →
MDCXW Earnings vs Peers
Earnings metrics vs comparable public companies
MDCXW Historical Earnings Data (2021–2025)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$25M | -127.4% | -$18M | $-1.96 | - | - |
| 2024 | -$11M | -109.9% | -$11M | $-1.16 | - | - |
| 2023 | -$5M | -214.0% | -$5M | $-1.06 | - | - |
| 2022 | -$2M | +17.7% | $-978,416 | $-0.21 | - | - |
| 2021 | -$2M | - | -$1M | $-0.26 | - | - |
Download Data
Export MDCXW earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
5+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
MDCXW — Frequently Asked Questions
Quick answers to the most common questions about buying MDCXW stock.
What is MDCXW earnings per share (EPS)?
MDCXW trailing twelve-month (TTM) diluted EPS is $-1.25, reflecting -69.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2021 to 2025 is available in the table on this page.
What is Medicus Pharma Ltd.'s net income?
Medicus Pharma Ltd. (MDCXW) trailing twelve-month net income is $-37M as of 2025. Earnings declined -69.0% year-over-year.
Is MDCXW profitable?
MDCXW is not currently profitable on a TTM basis, reporting a net loss of $-37M. Net margin is N/A. Investors should monitor for a return to profitability.
What is MDCXW's earnings growth rate?
MDCXW compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2021 to 2025.
What are MDCXW's profit margins?
Medicus Pharma Ltd. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -1599.4%.
Is MDCXW growing earnings?
MDCXW earnings are declining — EPS fell -69.0% year-over-year. TTM net income dropped to $-37M. This contrasts with the 5-year CAGR of N/A.
What was MDCXW's best earnings year?
Medicus Pharma Ltd.'s highest annual net income on record is $-2M, achieved in fiscal year 2022. Earnings history on this page spans 2021 to 2025 and includes all annual and quarterly figures.
What were MDCXW's earnings last quarter?
MDCXW's most recent reported quarter was Q1 2026. Net income was $-7M with diluted EPS of $-0.22. For a full breakdown of all quarters, see the quarterly earnings table on this page.